Pharmacokinetic Engineering of OX40-Blocking Anticalin Proteins Using Monomeric Plasma Half-Life Extension Domains.
Siegemund M, Oak P, Hansbauer EM, Allersdorfer A, Utschick K, Winter A, Grasmüller C, Galler G, Mayer JP, Weiche B, Prassler J, Kontermann RE, Rothe C.
Siegemund M, et al. Among authors: weiche b.
Front Pharmacol. 2021 Oct 25;12:759337. doi: 10.3389/fphar.2021.759337. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34759826
Free PMC article.